发明授权
US4927931A Preparation of alkyl-extended, alcohol-extended or amine-extended
piperazines
失效
烷基延伸的,延伸延伸的或延长胺的哌嗪的制备
- 专利标题: Preparation of alkyl-extended, alcohol-extended or amine-extended piperazines
- 专利标题(中): 烷基延伸的,延伸延伸的或延长胺的哌嗪的制备
-
申请号: US265610申请日: 1988-11-01
-
公开(公告)号: US4927931A公开(公告)日: 1990-05-22
- 发明人: David C. Molzahn , George E. Hartwell , Robert G. Bowman
- 申请人: David C. Molzahn , George E. Hartwell , Robert G. Bowman
- 申请人地址: MI Midland
- 专利权人: The Dow Chemical Company
- 当前专利权人: The Dow Chemical Company
- 当前专利权人地址: MI Midland
- 主分类号: C07D295/023
- IPC分类号: C07D295/023 ; C07D295/088 ; C07D295/13
摘要:
A process for preparing alkyl-extended, alcohol-extended or amine-extended piperazines or mixtures thereof comprising contacting a difunctional aliphatic alcohol with a reactant amine, wherein at least one of the aliphatic alcohol or the reactant amine contains a piperazine moiety, in the presence of a catalyst containing a Group VB metal oxide or a Group VB metal phosphate, or mixtures thereof. For example, monoethanolamine reacts with piperazine in the presence of a catalyst of niobic acid supported on hydrated alumina to yield predominantly N-(2-aminoethyl)piperazine. Also, N-hydroxyethylpiperazine reacts with piperazine in the presence of a catalyst of niobium phosphate to yield predominantly 1,2-bis(piperazinyl)ethane.
公开/授权文献
- US5985322A Method for the treatment of CNS disorders 公开/授权日:1999-11-16
信息查询